Quetiapine Fumarate contains not less than 99.0% and not more than 101.0% of C46H54N6O8S2, calculated on the anhydrous basis.

共有 1 個藥物證書使用此成份

延胡索酸喹硫平
Quetiapine Fumarate

• 申請商: 鴻傑藥品有限公司
• 適應症: 抗思覺失調症、雙極性疾患之躁症用藥
• 發證日期: 2019-08-19